Eva María P. P.
- Country
- Spain
- Department
- Dept. of Rheumatology
Research Overview
- Phase Ib Open-Label Study on Safety, Tolerability, and Pharmacokinetics of PIT565 in Rheumatoid Arthritis Patients
- A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-88545223 in Participants with Active Psoriatic Arthritis
- Phase 2b Study of Tulisokibart in Participants With Psoriatic Arthritis
Data & Insights
Has run more than one trial at 265 of 456 partner sites.
Specializations
Rheumatology Focus
This investigator specializes in treating psoriatic arthritis, particularly exploring innovative therapeutic approaches for patients with active disease manifestations.
- Advanced PsA Management
- Biologic Therapy Assessment
- Joint Disease Treatment
Their research extends to evaluating treatment efficacy in patients who have previous experience with biological therapies.
Therapeutic Assessment
The investigator's work centers on evaluating treatment efficacy and safety profiles of novel therapeutic agents for inflammatory joint conditions.
- Symptom Reduction Analysis
- Disease Activity Monitoring
- Treatment Response Evaluation
Their expertise includes assessing clinical responses at critical therapeutic timepoints.
Clinical Innovation
The investigator focuses on advanced therapeutic solutions for patients with complex autoimmune conditions affecting joints and skin.
- Novel Treatment Approaches
- Patient Response Assessment
- Clinical Outcomes Analysis
Their research encompasses comprehensive evaluation of therapeutic interventions in rheumatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.